NCT06483594View on ClinicalTrials.gov

Prediction and Prognostic Analysis of Liver Abscess Formation After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma (CHANCE 2407)

Not yet recruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2025

Conditions
TACEHCC - Hepatocellular CarcinomaLiver Abscess
All Listed Sponsors
collaborator

First Hospital of China Medical University

OTHER

collaborator

Zhongda Hospital

OTHER

collaborator

Changzhou No.2 People's Hospital

OTHER

collaborator

Tianjin Medical University General Hospital

OTHER

collaborator

Huazhong University of Science and Technology

OTHER

lead

Shengjing Hospital

OTHER

NCT06483594 - Prediction and Prognostic Analysis of Liver Abscess Formation After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma (CHANCE 2407) | Biotech Hunter | Biotech Hunter